Prevention of adverse events in which patients develop renal disease is important to all health care organizations that perform procedures using radiology with contrast. Contrast-induced nephropathy (CIN) is an adverse event related to the use of intravenous iodinated contrast agents during radiological procedures, and is reported to be the third most common cause of hospital-acquired acute renal failure. It carries a risk of permanent renal insufficiency, dialysis, and death, and remains a common and serious complication among at-risk patients after exposure of contrast agents. Proactive identification of patients at risk for CIN, as well as the implementation of preventative strategies are crucial for the prevention of harm, and the progression to End Stage Renal Disease (ESRD).
This recorded session features a discussion of the effect across the continuum of care, as well as implementation strategies that health care teams may take to reduce the risk of harm. Most importantly, this session features the lived experience of patients with End Stage Renal Disease (ESRD).